Stay updated on Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Sign up to get notified when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.

Latest updates to the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew revision: Revision: v3.3.3 has been added to the record history. The footer no longer shows the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedNew revision entry v3.3.2 was added and revision v3.3.1 was removed from the record history.SummaryDifference0.1%

- Check43 days agoChange DetectedRecord History shows a new revision (v3.3.1) replacing the previous v3.2.0, a metadata update that does not affect the study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the lapse in government funding notice; the page now shows only the standard government banner.SummaryDifference0.8%

- Check65 days agoChange DetectedMinor UI refresh observed on the Record History page, with slight changes to layout and styling of the version history table while core data remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the previous v3.1.0 tag.SummaryDifference13%

Stay in the know with updates to Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.